US 9539207
Method for delivering pramlintide into a lumen of the intestinal tract using a swallowable drug delivery
granted A61KA61K31/155A61K38/22
Quick answer
US patent 9539207 (Method for delivering pramlintide into a lumen of the intestinal tract using a swallowable drug delivery) held by Rani Therapeutics, LLC expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rani Therapeutics, LLC
- Grant date
- Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/155, A61K38/22, A61K38/26, A61K38/28